TABLE 3.
Combined clinical data for the cPass sVNTa
| GenScript cPass SARS-CoV-2 sVNT parameter | RT-qPCR result |
|
|---|---|---|
| Positive (n = 186) | Negative (n = 480) | |
| No. of positive results | 181 | 3 |
| No. of negative results | 5 | 477 |
| Sensitivity (%) | 97.30 | |
| Specificity (%) | 99.40 | |
| Accuracy (%) | 99.20 | |
| PPV (%) | 94.50 | |
| NPV (%) | 99.70 | |
a
Based on overall clinical data collected by 1 June 2020. Totals of 186 positive and 480 negative samples were verified by PCR and then screened by the sVNT. Sensitivity, specificity, accuracy, and positive and negative predictive values are shown. A prevalence of 10% was used for the calculations.